Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts $732.41 +0.45 (+0.06%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$731.25 -1.16 (-0.16%) As of 08/29/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Eli Lilly and Company Earnings Summary Eli Lilly and Company released Q2 2025 earnings on August 7, 2025, reporting an EPS of $6.31, which beat the consensus estimate of $5.59 by $0.72. Quarterly revenue rose 37.6% year-over-year to $15.56 billion, above analysts' expectations of $14.40 billion. With a trailing EPS of $15.30 and a P/E Ratio of 47.87, Eli Lilly and Company's earnings are expected to grow 32.54% next year, from $23.48 to $31.12 per share. Upcoming Q3 Earnings DateOct. 29Before Market OpensEstimatedConsensus EPS (Aug. 7) $5.59 Actual EPS (Aug. 7) $6.31 Beat By $0.72 Actual Revenue (Aug. 7) $15.56BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Quarterly Report (10-Q)SEC FilingLLY Upcoming EarningsEli Lilly and Company's next earnings date is estimated for Wednesday, October 29, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Eli Lilly and Company Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eli Lilly and Company and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataLLY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LLY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Eli Lilly and Company Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$2.68$4.49$3.59Q2 20252$5.40$5.53$5.47Q3 20252$6.04$6.30$6.17Q4 20251$6.57$6.57$6.57 FY 2025 7 $20.69 $22.89 $21.79 Q2 20261$7.21$7.21$7.21Q3 20261$8.20$8.20$8.20Q4 20261$9.04$9.04$9.04 2026 3 $24.45 $24.45 $24.45 Q1 20271$7.90$7.90$7.90 Eli Lilly and Company Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/29/2025(Estimated)--------8/7/2025Q2 2025$5.59$6.31+$0.72$6.29$14.40B$15.56B5/1/2025Q1 2025$4.64$3.34 -$1.30$3.06$12.77B$12.73B2/6/2025Q4 2024$5.45$5.32 -$0.13$4.88$13.42B-10/30/2024Q3 2024$1.52$1.18 -$0.34$1.29$12.09B$11.44B8/8/2024Q2 2024$2.64$3.92+$1.28$4.56$9.83B$11.30B5/6/2024Q1 2024$2.53$2.58+$0.05$2.68$8.94B$8.77B2/6/2024Q4 2023$2.30$2.49+$0.19$2.56$8.95B$9.35B11/2/2023Q3 2023-$0.08$0.10+$0.18$0.26$8.88B$9.50B Eli Lilly and Company Earnings - Frequently Asked Questions When is Eli Lilly and Company's earnings date? Eli Lilly and Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 29th, 2025 based off last year's report dates. Learn more on LLY's earnings history. What guidance has Eli Lilly and Company issued on next quarter's earnings? Eli Lilly and Company updated its FY 2025 earnings guidance on Thursday, August, 7th. The company provided EPS guidance of 21.750-23.000 for the period, compared to the consensus estimate of 21.587. The company issued revenue guidance of $60.0 billion-$62.0 billion, compared to the consensus revenue estimate of $59.5 billion. Did Eli Lilly and Company beat their earnings estimates last quarter? In the previous quarter, Eli Lilly and Company (NYSE:LLY) reported $6.31 earnings per share (EPS) to beat the analysts' consensus estimate of $5.59 by $0.72. Learn more on analysts' earnings estimate vs. LLY's actual earnings. How can I listen to Eli Lilly and Company's earnings conference call? The conference call for Eli Lilly and Company's latest earnings report can be listened to online. Listen to Conference Call How can I read Eli Lilly and Company's conference call transcript? The conference call transcript for Eli Lilly and Company's latest earnings report can be read online. Read Transcript How can I view Eli Lilly and Company's earnings report? Eli Lilly and Company's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $45.04 billion. How much profit does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded net income of $10.59 billion. LLY has generated $15.30 earnings per share over the last four quarters. What is Eli Lilly and Company's price-to-earnings ratio? Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 47.87 and a forward price-to-earnings ratio of 31.19. The price/earnings-to-growth ratio is 1.02. What is Eli Lilly and Company's EPS forecast for next year? Eli Lilly and Company's earnings are expected to grow from $23.48 per share to $31.12 per share in the next year, which is a 32.54% increase. More Earnings Resources from MarketBeat Related Companies Amgen Earnings Results Biogen Earnings Results Incyte Earnings Results Moderna Earnings Results Viking Therapeutics Earnings Results Vertex Pharmaceuticals Earnings Results AbbVie Earnings Results Johnson & Johnson Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B Contract This page (NYSE:LLY) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LLY Stock Alerts